81 related articles for article (PubMed ID: 30693645)
1. Association of APOBEC3 deletion with cancer risk: A meta-analysis of 26 225 cases and 37 201 controls.
Hashemi M; Moazeni-Roodi A; Taheri M
Asia Pac J Clin Oncol; 2019 Dec; 15(6):275-287. PubMed ID: 30693645
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3 deletion increases the risk of breast cancer: a meta-analysis.
Han Y; Qi Q; He Q; Sun M; Wang S; Zhou G; Sun Y
Oncotarget; 2016 Nov; 7(46):74979-74986. PubMed ID: 27602762
[TBL] [Abstract][Full Text] [Related]
3. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
[TBL] [Abstract][Full Text] [Related]
4. Association between angiotensin-converting enzyme gene insertion/deletion polymorphism and susceptibility to preterm birth: A case-control study and meta-analysis.
Hočevar K; Peterlin A; Jovanović AM; Božović A; Ristanović M; Tul N; Peterlin B
Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():122-128. PubMed ID: 30366344
[TBL] [Abstract][Full Text] [Related]
5. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
7. Lack of Association between miR-605 rs2043556 Polymorphism and Overall Cancer Risk: A Meta-analysis of Case-control Studies.
Moazeni-Roodi A; Ghavami S; Hashemi M
Microrna; 2019; 8(2):94-100. PubMed ID: 30514199
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry.
Xuan D; Li G; Cai Q; Deming-Halverson S; Shrubsole MJ; Shu XO; Kelley MC; Zheng W; Long J
Carcinogenesis; 2013 Oct; 34(10):2240-3. PubMed ID: 23715497
[TBL] [Abstract][Full Text] [Related]
9. Association of the PTEN IVS4 (rs3830675) gene polymorphism with reduced risk of cancer: evidence from a meta-analysis.
Mandal RK; Akhter N; Irshad M; Panda AK; Ali A; Haque S
Asian Pac J Cancer Prev; 2015; 16(3):897-902. PubMed ID: 25735379
[TBL] [Abstract][Full Text] [Related]
10. Association between rs1862513 and rs3745367 Genetic Polymorphisms of Resistin and Risk of Cancer: A Meta-Analysis.
Hashemi M; Bahari G; Tabasi F; Moazeni-Roodi A; Ghavami S
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2709-2716. PubMed ID: 30360595
[TBL] [Abstract][Full Text] [Related]
11. The insertion/deletion (I/D) polymorphism in the angiotensin-converting enzyme gene and erectile dysfunction risk: a meta-analysis.
Zhang T; Li WL; He XF; Wu ZY; Liu LH; He SH; Wei AY
Andrology; 2013 Mar; 1(2):274-80. PubMed ID: 23413140
[TBL] [Abstract][Full Text] [Related]
12. APOBEC3A/B deletion polymorphism and cancer risk.
Gansmo LB; Romundstad P; Hveem K; Vatten L; Nik-Zainal S; Lønning PE; Knappskog S
Carcinogenesis; 2018 Feb; 39(2):118-124. PubMed ID: 29140415
[TBL] [Abstract][Full Text] [Related]
13. Updated meta-analysis of NFkappaB1 -94ins/Delattg promoter polymorphism and cancer risk based on 19 case-control studies.
Wang X; Lu P; Xu L; Xu Y; Shi Z; Xu J; Wang Y; Zhang J; Wang X; Cao L; Liu N; Yin Y; You Y
Asian Pac J Cancer Prev; 2011; 12(10):2479-84. PubMed ID: 22320942
[TBL] [Abstract][Full Text] [Related]
14. APOBEC3 Deletion is Associated with Breast Cancer Risk in a Sample of Southeast Iranian Population.
Rezaei M; Hashemi M; Hashemi SM; Mashhadi MA; Taheri M
Int J Mol Cell Med; 2015; 4(2):103-8. PubMed ID: 26261799
[TBL] [Abstract][Full Text] [Related]
15. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
[TBL] [Abstract][Full Text] [Related]
16. Association of angiotensin I converting enzyme insertion/deletion polymorphism with breast cancer: a meta-analysis.
Sun M; Liu C; Wei F; Zhong J; Sun Y
J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):611-6. PubMed ID: 21546404
[TBL] [Abstract][Full Text] [Related]
17. Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer.
Gansmo LB; Sofiyeva N; Bjørnslett M; Romundstad P; Hveem K; Vatten L; Dørum A; Lønning PE; Knappskog S
Sci Rep; 2021 Dec; 11(1):23463. PubMed ID: 34873230
[TBL] [Abstract][Full Text] [Related]
18. Association between BRCA1 rs799917 polymorphism and breast cancer risk: A meta-analysis of 19,878 subjects.
Qin TT; Chen T; Zhang Q; Du HN; Shu YQ; Luo K; Zhu LJ
Biomed Pharmacother; 2014 Sep; 68(7):905-10. PubMed ID: 25194442
[TBL] [Abstract][Full Text] [Related]
19. The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis.
Huang Q; Wang C; Qiu LJ; Shao F; Yu JH
Breast Cancer Res Treat; 2011 Aug; 129(1):191-4. PubMed ID: 21390492
[TBL] [Abstract][Full Text] [Related]
20. Association of Interleukin-10 -1082A>G (rs1800896) Polymorphism with Predisposition to Breast Cancer: a Meta-Analysis based on 17 Case-Control Studies.
Abedinzadeh M; Neamatzadeh H; Jafari M; Forat-Yazdi M; Nasiri R; Farahnak S; Foroughi E; Zare-Shehneh M
Rev Assoc Med Bras (1992); 2018 Aug; 64(8):756-764. PubMed ID: 30673047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
